Immmunopathogenesis of rheumatoid arthritis: Induction of arthritogenic autoimmune responses by proinflammatory stimuli

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 391-400

  Hoffmann, Markus ^a   Hayer, Silvia ^a   Steiner, Guenter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Animal models; Autoantibodies; Rheumatoid arthritis; T cells

Indexed keywords

AUTOANTIGEN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; IMMUNOGLOBULIN G; PRISTANE; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR;

CONFERENCE PAPER; GENE OVEREXPRESSION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PROTEIN TARGETING; RAT; RHEUMATOID ARTHRITIS; SEROLOGY; TRANSGENIC MOUSE; TRANSGENIC RAT;

ANIMALIA; MUS; MUS MUSCULUS; RATTUS;

EID: 69949117222     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04753.x     Document Type: Conference Paper

References (41)

1. Bowes J. & A. Barton. 2008. Recent advances in the genetics of RA susceptibility. Rheumatology 47: 399-402.
2. Dorner, T. et al. 2004. Rheumatoid factor revisited. Curr. Op. Rheum. 16: 246-253.
3. Mewar D. & A.G. Wilson. 2006. Autoantibodies in rheumatoid arthritis: a review. Biomed. Pharmacother. 60: 648-655.
4. Steiner, G. 2007. Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools. Clin. Rev. Allergy Immunol. 32: 23-36.
5. Steiner, G. & G. Serre. 2008. Autoantibodies in rheumatoid arthritis. In Rheumatology, Vol. 4rd edition. M.C. Hochberg, et al., Eds.: 819-827. Mosby Elsevier. London.
6. Klareskog, L. et al. 2008. Antibodies to citrullinated proteins in arthritis: pathology and promise. Curr. Opin. Rheumatol. 20: 300-305.
7. Vincent, C. et al. 2005. Autoantibodies to citrulli-nated proteins: ACPA. Autoimmunity 38: 17-24.
8. Cope, A.P., H. Schulze-Koops & M. Aringer. 2007. The central role of T cells in rheumatoid arthritis. Clin. Exp. Rheumatol. 25: S4-11.
9. Kassiotis, G. et al. 1999. TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune en-cephalomyelitis. Eur. J. Immunol. 29: 774-780.
10. Kollias, G. et al. 1999. The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann. Rheum. Dis. 58: 1i32-39.
11. Hayer, S. et al. 2005. Aberrant expression of the au-toantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice. J. Immunol. 175: 8327-8336.
12. Keffer, J. et al. 1991. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10: 4025-4031.
13. Dumortier, H. et al. 2000. B and T cell responses to the spliceosomal heterogeneous nuclear ribonucleo-proteins A2 and B1 in normal and lupus mice. J. Immunol. 165: 2297-2305.
14. Holmdahl, R. et al. 2001. Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol. Rev. 184: 184-202.
15. Hoffmann et al. 2007. The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis. J. Immunol. 179: 7568-7576.
16. Vingsbo, C. et al. 1996. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major his-tocompatibility complex and non-major histocom-patibility complex genes. Am. J. Pathol. 149: 1675-1683.
17. Holmdahl, R. et al. 1992. Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease. Immunology 76: 197-202.
18. Holmberg, J. et al. 2006. Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthrito-genic T cells in the rat. J. Immunol. 176: 1172-1179.
19. Fritsch, et al. 2002. Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ri-bonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis. J. Immunol. 169: 1068-1076.
20. Hassfeld, W. et al. 1995. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus. Arthritis Rheum. 38: 777-785.
21. Schett, G. et al. 2008. B-cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: Identification of a new specific antibody marker for active lupus disease. Ann. Rheum. Dis. Epub ahead of print (May 2008).
22. Skriner, K. et al. 1997. Anti-A2/RA33 autoantibod-ies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleo-protein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease. J. Clin. Invest. 100: 127-135.
23. Nell, V. et al. 2005. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann. Rheum. Dis. 64: 1731-1736.
24. Kamma, H. et al. 1999. Molecular characterization of the hnRNP A2/B1 proteins: tissue-specific expression and novel isoforms. Exp. Cell Res. 246: 399-411.
25. Vossenaar, E.R. & W.J. van Venrooij. 2004. Citrul-linated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res. Ther. 6: 107-111.
26. Vossenaar, E.R. et al. 2004. The presence of citrulli-nated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum. 50: 3494.
27. Edwards, C.J. & C. Cooper. 2006. Early environmental exposure and the development of lupus. Lupus 15: 814-819.
28. Edwards C.J. & C. Cooper. 2006. Early environmental factors and rheumatoid arthritis. Clin. Exp. Immunol. 143: 1-5.
29. Holmoy, T. & A.L. Hestvik. 2008. Multiple sclerosis: immunopathogenesis and controversies in defining the cause. Curr. Opin. Infect. Dis. 21: 271-278.
30. Klareskog, L. et al. 2006. Genes, environment and immunity in the development ofrheumatoid arthritis. Curr. Opin. Immunol. 18: 650-655.
31. Klareskog, L. et al. 2006. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination [see comment]. Arthritis Rheum. 54: 38-46.
32. Kobayashi, S. et al. 2008. Molecular aspects of rheumatoid arthritis: role of environmental factors. FEBS J. 275: 4456-4462.
33. Richards, H.B. et al. 1999. Disparate T cell requirements of two subsets of lupus-specific autoantibod-ies in pristane-treated mice. Clin. Exp. Immunol. 115: 547-553.
34. Satoh, M.K. et al. 1995. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc. Natl. Acad. Sci. USA 92: 10934-10938.
35. Calvani N. et al. 2005. Induction of apoptosis by the hydrocarbon oil pristane: implications for pristane-induced lupus. J. Immunol. 175: 4777-4782.
36. Dahlgren, J.T. et al. 2007. Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional study. Environ. Health. 6: 8-22.
37. Sverdrup, B. et al. Epidemiological Investigation of Rheumatoid Arthritis Study. 2005. Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study. Arthritis Res. Ther. 7: R1296-1303.
38. Brockstedt, E. et al. 1998. Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleo-protein A1 by caspase 3 [erratum appears in J Biol Chem 1998 Dec 11;273(50): 33884]. J. Biol. Chem. 273: 28057-28064.
39. Hoffmann, M.H. & G. Steiner. 2009. A common pathway for all autoimmune diseases? The unholy alliance of environment, cell death and nucleic acids. Current Immunology Reviews 5: 69-88.
40. Skriner, K. et al. 2008. AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases. Arthritis Rheum. 58: 511-520.
41. Suzuki, A., R. Yamada & K. Yamamoto. 2007. Cit-rullination by peptidylarginine deiminase in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 1108: 323-339.